Contract Pharma Webinar: Building Trust Between Clinical Trial Stakeholders through a DCT Framework
In 2022, a record 1,300 trials will launch with a decentralized or virtual component according to Clinical Trials Arena. This growth is greatly impacting our industry, changing the ways in which sites interact with patients and study teams.
Clinical research sites face many challenges to retain the number of patients needed to successfully complete and validate the integrity of a study. Sites continually strive to improve patient recruitment and engagement practices for clinical trials to provide sponsors with the critical data they need to bring new medications to market safely.
As roles continue to evolve, it’s paramount to ensure that the sites are engaged and supported in a way that makes their everyday work easier and more effective.
In this webinar, a panel of industry experts will showcase how to design a framework of decentralized offerings that provide greater ease of use, effectiveness, and flexibility for sites for every type of research setting; decentralized/hybrid, virtual, or in-person. In addition, they will discuss how DCT solutions and site partners are creating an impact to improve DEI while optimizing clinical research for patients.
James Riddle, MCSE, CIP, CPIA, CRQM
VP of Research Services & Strategic Consulting
James has served as a leader of human subject protection at one of the nation’s largest independent cancer research centers and an active leader for PRIM&R.